ICMR
What can India learn from its response to the pandemic?

It has been one year since the Narendra Modi government in India imposed a nationwide lockdown in response to the COVID-19 pandemic.

MSF reports civilians killed by Ethiopian soldiers in Tigray and other stories

Today we take a look at recent reports of the killing of civilians in the Tigray region, custodial deaths of Indigenous people in Australia, police repression against a protest in Jordan, and the key lessons learned as India marks 1 year of the Covid-19 lockdown

Covaxin trials: What 81% “interim efficacy” means

Bharat Biotech has claimed in a press release that its Covid-19 vaccine candidate, Covaxin, showed 81% efficacy in the “first interim analysis” of phase-3 trials.

India covid India’s failed lockdown: devastating the poor, weakening the fight against COVID-19

A large-scale migration of people during the lockdown will only spread infections rapidly across the country. Meanwhile, food and other supplies are drying up as supply chains are slowly coming apart under pressure.

Drug design today Drug design today: Large molecules or small molecules?

Veteran scientist Satyajit Rath talks about the differences, usefulness and the pros and cons of small and big molecules as constituents of drugs.

    × To Subscribe